Key result
Continuation of preoperative aspirin until the day of surgery did not increase postoperative chest tube drainage or transfusion requirements compared to stopping aspirin five days prior.
Why the study?
Practice for routine continuation of preoperative aspirin remains inconsistent due to concerns regarding increased postoperative bleeding, despite evidence supporting its continuation to improve coronary artery bypass outcomes.
Does continuing preoperative aspirin 75 mg until the day of surgery increase postoperative bleeding in patients undergoing off-pump coronary artery bypass grafting?
Cohort (n=74)
No
Does continuing preoperative aspirin 75 mg until the day of surgery increase postoperative bleeding in patients undergoing off-pump coronary artery bypass grafting?
Continuing low-dose aspirin (75 mg) until the day of off-pump coronary artery bypass grafting does not increase postoperative bleeding or transfusion requirements compared to stopping it five days prior.
Answers are grounded in this paper and cite their sources.
May support continuing aspirin until off-pump CABG without excess bleeding; leaves open need for RCTs before practice change.
Background Despite ample evidence of continuing preoperative aspirin to improve coronary artery bypass surgery outcomes, practice for the routine continuation of preoperative aspirin is inconsistent due to concern for increased postoperative bleeding. The purpose of this study was to investigate preoperative aspirin use and its effect on postoperative bleeding after off-pump coronary artery bypass grafting (OPCABG). Methodology This cohort study involved patients (n = 74) who underwent OPCABG at a single center between August 2017 and January 2018. After considering the inclusion and exclusion criteria, the patients were divided into two groups: one (n = 37) received tablet aspirin 75 mg till the day of the surgery, and for the other group (n = 37) aspirin was stopped five days before the surgery. Postoperative bleeding was recorded in both groups. After considering preoperative, intraoperative, and postoperative variables, statistical analysis was performed. Results There was no significant difference between the two groups concerning peroperative and postoperative variables. In addition, no significant difference was observed between the two groups in chest tube drainage at one, two, three, twenty-four, forty-eight, and seventy-two hours (p = 0.845, 0.126, 0.568, 0.478, 0.342, and 0.717, respectively). No significant difference was seen in the transfusion requirement of blood and fresh frozen plasma (FFP). Conclusions Continuation of preoperative aspirin till the day of the surgery is neither associated with an increase in chest tube drainage, reoperation for bleeding complications nor transfusion of blood and FFP.
No takes yet. Share an insight, caveat, or question.
Al-Manzo et al. (2021) conducted a cohort in Coronary Artery Disease undergoing Off-Pump Coronary Artery Bypass Grafting (n=74). Preoperative continuation of aspirin vs. Aspirin stopped 5 days before surgery was evaluated on Total amount of postoperative chest tube drainage. Continuation of preoperative aspirin until the day of surgery did not increase postoperative chest tube drainage or transfusion requirements compared to stopping aspirin five days prior.
Synapse has enriched 10 related papers. Consider them for comparative context: